Dissemination of Alerts within the Trust for Reusable Medical Devices

Similar documents
Trial, Loan or Lease - of Medical Devices from Manufacturers/Suppliers

Medical Devices Policy

Standard Operating Procedure 5 (SOP 5) Escalation

Standard Operating Procedure 3 (SOP 3) Template. Advance Decision To Refuse Treatment &Advance Statement

Trust Policy and Procedure Document Ref. No: PP (17) 283. Central Alerting System (CAS) Policy and Procedure. For use in: For use by: For use for:

Revalidation for Nurses

Central Alerting System (CAS) Policy

Clinical and Offensive Waste

Reporting an Incident

Policy for the Management of Safety Alerts issued via the Central Alerting System (CAS)

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Central Alert System (CAS) Policy and Procedure

Elmarie Swanepoel 24 th September 2017

Hospital Managers Appeal and Renewal Hearings

Burton Hospitals NHS Foundation Trust. On: 25 January Review Date: December Corporate / Directorate. Department Responsible for Review:

Visiting Celebrities, VIPs and other Official Visitors

Unless this copy has been taken directly from the Trust intranet site (Pandora) there is no assurance that this is the most up to date version

The Prescribing, Monitoring and Administration of Depot / Long Acting IM Medication within Community Mental Health Services

Central Alert System (CAS) RISK MANAGEMENT POLICY /PROCEDURE: CENTRAL ALERT SYSTEM (CAS)

Medical Devices Management Policy

Consulted With Individual/Body Date Medical Devices Group August 2014

Family Nurse Partnership Caseload Management

Isolation Care of Patients in Isolation due to Infection or Disease

Reconciliation of Medicines on Admission to Hospital

CLOZAPINE ONE STOP CLINIC POLICY (SANDWELL) Revised

Research Staff Training

ASBESTOS MANAGEMENT POLICY

RQIA Provider Guidance Independent Clinic Private Doctor Service

RQIA Provider Guidance Independent Clinic Private Doctor Service

Locked Door. Target Audience. Who Should Read This Policy. All Inpatient Staff

Medical Devices Management Policy

Agreement between: Care Quality Commission and NHS Commissioning Board

POLICY ON THE IMPLEMENTATION OF NICE GUID ANCE

ASBESTOS POLICY. Version: 3 Senior Managers Operational Group Date ratified: March 2016

Learning from Deaths Policy A Framework for Identifying, Reporting, Investigating and Learning from Deaths in Care.

JOB DESCRIPTION. Specialist Practitioner of Transfusion for Shrewsbury, Telford and surrounding community hospitals. Grade:- Band 7 Line Manager:-

Decontamination of Medical and Laboratory Equipment Prior to Maintenance or Transportation

Safeguarding of Vulnerable Adults. Annual Report

Healthwatch England Escalation Guidance

Review of Terms of Reference of Quality Assurance Committee

The safety of every patient we care for is our number one priority

Quality Committee Terms of Reference

NHS and independent ambulance services

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.

INFECTION CONTROL SURVEILLANCE POLICY

Infection Prevention and Control: Audit Policy

Central Alerting System (CAS) Policy

Enforcement (if provider is not meeting the regulation)

Supervision Policy. NHS Litigation Authority Risk Management Standards

Date 4 th September 2015 Dr Ruth Charlton, Joint Medical Director / Jill Down, Associate Director of Quality Laura Rowe, Compliance Manager

Document Details Clinical Audit Policy

Estates and Facilities Alert

Patient Alert. Target Audience. Who Should Read This Policy. All Staff

Keele Clinical Trials Unit

Framework for managing performer concerns NHS (Performers Lists) (England) Regulations 2013

2. DEVELOPING AND DELIVERING A SINGLE GOVERNANCE STRUCTURE

Debbie Edwards Interim Deputy Director of Nursing Gail Naylor- Executive Director of Nursing & Midwifery. Safety & Quality Committee

NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST. Documentation Control. Central Alerting System (CAS) Dissemination Procedure

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.

Head of Joint Commissioning committee/individual: Effective from: 6 th February Review date: April 2017

Learning from Deaths Policy. This policy applies Trust wide

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

Guidance on NHS Wales Patient Safety Solutions. December 2014

Medical Devices Policy

Section 18 Absent without Leave Photographing Patients

Mortality Policy. Learning from Deaths

SUP 08 Operational procedures for Medical Gas Pipeline Systems (MGPS) Unified procedures for use within NHS Scotland

Version: 2. Date adopted: 17 May publication: Review date: September Expiry date: March 2019

NHS East and North Hertfordshire Clinical Commissioning Group. Quality Committee. Terms of Reference Version 4.0

Electrical Services Policy

COMMUNITY AND OLDER PEOPLE S MENTAL HEALTH SERVICE FRAMEWORK FOR:

Appendix 1. Policy on the Dissemination, Implementation and Monitoring of National Clinical Guidance

DATA QUALITY STRATEGY IM&T DEPARTMENT

Warrington CCG Operational Safeguarding Children Health Forum. Terms of Reference

Action required: To agree the process by which Governors will meet with the inspection team.

Methods: Commissioning through Evaluation

How CQC monitors, inspects and regulates independent doctors and clinics providing primary care

Nursing, Health Visiting and Allied Health Professional Preceptorship Policy

Quality Assurance Framework

RISK MANAGEMENT EXPERT SUPPORT TO MANAGE RISK AND IMPROVE PATIENT SAFETY

Executive Director of Nursing and Operations Tony Gray Head of Safety and Patient Experience Craig Newby Patient Safety Officer

Slips Trips and Falls Policy (Staff and Others)

Governance and Quality Committee Review. Wendy Pugh Director of Operations and Nursing. Innovation Tom Jinks - Governance Manager.

Quality Governance (Audit, Compliance and CQC) Manager

BOARD OF DIRECTORS MEETING (Open)

Safeguarding Strategy

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.

MATERNITY SERVICES RISK MANAGEMENT STRATEGY

MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC

Infection Prevention and Control Assurance

Under 18s Admission to Adult Mental Health Ward: Standard Operating Procedure

Facilities and Estates. Safety and Suitability of Premises Policy. Document Control Summary. Contents. New. Status:

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

Revised Terms of Reference Trust Management Committee

Quality and Governance Committee. Terms of Reference

RISK MANAGEMENT STRATEGY

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.

Annual Complaints Report 2014/15

Unique Identifier: Review Date: November Issue Status: Approved Version No: 1.4 Issue Date: November 2017

102/14(ii) Bridgewater Board Date. Thursday 5 June Agenda item. Safe Staffing April 2014 Review

Children Education & Families Health and Safety Arrangements Part 3

Transcription:

Standard Operating Procedure 12 (SOP 12) Dissemination of Alerts within the Trust for Reusable Medical Devices Why we have a procedure? This procedure sets out the steps to be followed to ensure that a clear process is in place for disseminating/actioning MDA s and FSN s relating to re-usable medical devices. Implementation of the procedure will contribute to the safety of patients, users and others. This procedure is in compliance with CQC Fundamental Standards- section B and E of Regulation 12: Safe Care and Treatment and sections C and E of Regulation 15: Premises and Equipment. The intention of regulation 12 is to ensure that the equipment used by the service provider for providing care or treatment to a service user is safe for such use and used in a safe way. The intention of regulation 15 is to ensure equipment used by the service provider is suitable for the purpose for which it is being used and properly maintained. What overarching policy the procedure links to? Medical Devices Policy Which services of the trust does this apply to? Where is it in operation? Group Inpatients Community Locations Mental Health Services all Learning Disabilities Services all Children and Young People Services all Who does the procedure apply to? Governance Assurance Unit Medical Device Managers Ward/Department Managers When should the procedure be applied? When GAU receive MDA and FSN alerts relating to re-usable medical devices Dissemination of Alerts Within BCPFT for Reusable Medical Devices Page 1 of 7 Version 1.0 December 2015

When wards/departments are responding to GAU alerts relating to re-useable medical devices How to carry out this procedure All alerts relevant to the service identified are received by GAU Reusable medical equipment related device alerts emailed to Lead Managers of EBME Department at New Cross Hospital, Wolverhampton to identify if the affected devices are located within the BCPFT by checking the F2 Database If the alert is not relevant EBME Manager completes feedback form and returns it to GAU within two working days and enters data on their MHRA Monitor spreadsheet If the alert is relevant EBME Manager will identify departments/sites where the affected devices are located by completing the feedback form within two working days and upload alert into F2 database Relevant Alerts are sent to nominated Medical Device & Governance leads in each Group within one working day for actioning/awareness. They will include a deadline for completion Responses are collated by leads and one response sent to GAU identifying actions taken within agreed timescales. Withdrawal of affected devices alert GAU to alert the relevant Groups of the need to withdraw from service the affected devices and place in secure location and arrange collection in accordance with the alert recommendations Local action plans and any withdrawal of devices should be highlighted on the response form to GAU with a copy of all action plans On completion GAU to make EBME Managers aware to close the alert on their MHRA Monitor spreadsheet Modification of device part alert Where recommendations for parts to be replaced i.e. new battery/upgraded internal circuit board etc., EBME Managers will upload alert into F2 database and log work requests for all relevant individual devices for the relevant work to be carried out by EBME staff EBME Managers will give updates of progress and completion to GAU via the feedback form EBME Manager will close the alert on their MHRA Monitor spreadsheet when actions completed What do these terms mean? MDA - Medical Devices Alerts are the prime means of communicating safety information to healthcare environments on medical devices. MDA s are prepared by the MHRA and are distributed nationally with the same reference, content and format FSN - Field Safety Notice is an important communication about the safety of a medical device that is sent to customers by a device manufacturer, or their representative Dissemination of Alerts Within BCPFT for Reusable Medical Devices Page 2 of 7 Version 1.0 December 2015

FSNs tell you what you need to do to reduce the specified risks of using the medical device. The actions are referred to as Field Safety Corrective Actions (FSCAs) CQC - Care Quality Commission is the independent regulator of health and adult social care in England. They make sure health and social care services provide people with safe, effective, compassionate, high-quality care and encourage them to improve GAU - Governance Assurance Unit support the Groups at BCPFT to implement and monitor their risk/safety and governance framework. They also provide assurance to the Board that the Trust is compliant with statutory regulations and is managing and monitoring risk and governance across all services EBME Department - Electro-biomedical Engineering Department is responsible for the maintenance, repair and management of medical equipment within the Trust, safeguarding both patients and users from any risk that may occur while using medical equipment F2 Database - F2 is a Medical Asset Management database system MHRA - Medicines and Healthcare products Regulatory Agency is a government body which was set up in 2003 to bring together the functions of Medicines Control Agency and Medical Devices Agency. These include the regulation of medicines and medical devices and equipment used in healthcare and the investigation of harmful incidents Dissemination of Alerts Within BCPFT for Reusable Medical Devices Page 3 of 7 Version 1.0 December 2015

Flowchart of Process of Dissemination of Alerts within the Trust for Reusable Medical Devices Alerts received by Governance Assurance Unit (GAU). All alerts relevant to the service identified Reusable medical equipment related device alerts sent to Lead Managers of EBME to identify if the affected devices are located within the BCPFT. Alert not relevant Alert relevant EBME Manager will identify departments/sites where the affected devices are located by completing the feedback form to GAU within two working days EBME Manager completes feedback form and returns it to GAU within two working days GAU will send the alert to all relevant Groups for actioning /awareness Responses are collated by Group Governance leads and 1 response sent to GAU identifying actions taken within agreed timescales Withdrawal of affected devices alert GAU to alert the relevant Groups to withdraw affected devices, place in secure location and arrange collection in accordance with the alert recommendations. Modification of device part alert EBME Managers will upload alert into F2 database and log work requests for all relevant individual devices for the relevant work to be carried out by EBME staff Local action plans and any withdrawal of devices should be highlighted on the response form to GAU with a copy of all action plans. EBME Managers will give updates of progress and completion to GAU via the feedback form. On completion GAU to inform EBME Managers. Dissemination of Alerts Within BCPFT for Reusable Medical Devices Page 4 of 7 Version 1.0 December 2015

Where do I go for further advice or information? Medical Devices Group Ensure that the Trust has access to appropriate expert advice as required to support this procedure Review incidents including governance issues relating to medical device management Receive quarterly incident analysis reports related to medical device related incidents reported to MHRA Receive quarterly performance reports related to the dissemination of MHRA medical device alerts across the Trust Governance Assurance Unit Provide central point of contact for the Medicines and Healthcare products Regulatory Agency (MHRA) Disseminate safety alerts and other notices issued by agencies such as NHS England, Medicines and Healthcare Products Regulatory Agency (MHRA) and NHS Estates to a nominated representative in each Service when relevant Maintain a record of actions taken as a result of the safety notices/alerts Produce a monthly Central Alerting System (CAS) status for the Quality and Safety Steering Group Ensure failure to meet deadlines for action is recorded on the Trust risk register and escalated in line with the Trusts escalation procedures Ensure incidents involving medical devices are appropriately investigated and reported to the MHRA Nominated Medical Device Leads (Clinical Groups) and Team Leaders in Community Services Key point of contact for ensuring Medical Device Alerts, Patient Safety Notices and other Safety Alerts are acknowledged by their managers and to act on the managers behalf when they are unavailable Team Leaders/Ward & Department Managers/Senior Nurses/Operational Managers Take ownership and be responsible for the medical devices used in their areas Infection Prevention & Control Team Advise accordingly in line with this procedure The Medical Physics and Clinical Engineering department Assist the Trust with the investigation of incidents involving medical devices Technical and clinical support of the equipment and staff during its life time Training Staff may receive training in relation to this procedure, where it is identified in their appraisal as part of the specific development needs for their role and responsibilities. Please refer to the Trust s Mandatory & Risk Management Training Needs Analysis for Dissemination of Alerts Within BCPFT for Reusable Medical Devices Page 5 of 7 Version 1.0 December 2015

further details on training requirements, target audiences and update frequencies. Monitoring / Review of this Procedure In the event of planned change in the process(es) described within this document or an incident involving the described process(es) within the review cycle, this SOP will be reviewed and revised as necessary to maintain its accuracy and effectiveness Equality Impact Assessment Please refer to overarching policy Data Protection Act and Freedom of Information Act Please refer to overarching policy Dissemination of Alerts Within BCPFT for Reusable Medical Devices Page 6 of 7 Version 1.0 December 2015

Standard Operating Procedure Details Unique Identifier for this SOP is State if SOP is New or Revised BCPFT-CLIN-POL-12-1 New Policy Category Executive Director whose portfolio this SOP comes under Policy Lead/Author Job titles only Committee/Group Responsible for Approval of this SOP Month/year consultation process completed Clinical Deputy Chief Executive & Director of Resources Medical Devices Group Medical Devices Group April 2015 Month/year SOP was approved November 2015 Next review due December 2018 Disclosure Status Key words relating to this SOP B can be disclosed to patients and the public MDA, FSN, GAU alert, MHRA, medical devices warning, safety information Review and Amendment History Version Date Description of Change 1.0 Dec 2015 New Procedure established to supplement Medical Devices Policy Dissemination of Alerts Within BCPFT for Reusable Medical Devices Page 7 of 7 Version 1.0 December 2015